Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2014
08/21/2014US20140235646 Methods and Compositions for the Treatment of Body Weight Related Disorders
08/21/2014US20140235641 Pyrazole carboxamides as janus kinase inhibitors
08/21/2014US20140235640 Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
08/21/2014US20140235638 Anti-Infective Agents and Uses Thereof
08/21/2014US20140235637 Compounds and methods for treating inflammatory and fibrotic disorders
08/21/2014US20140235629 Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer
08/21/2014US20140235626 Pyridine derivatives and a pharmaceutical composition for inhibiting bace1 containing them
08/21/2014US20140235624 Sweet flavor modifier
08/21/2014US20140235623 Modulation of chemosensory receptors and ligands associated therewith
08/21/2014US20140235622 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/21/2014US20140235620 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
08/21/2014US20140235613 Substituted diaryl azetidine derivatives as sphingosine receptor modulators
08/21/2014US20140235609 Carbamate/urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors
08/21/2014US20140235608 Pyridinedione carboxamide inhibitors of endothelial lipase
08/21/2014US20140235593 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
08/21/2014US20140235584 Biaryl heterocycle substituted oxazolidinone antibacterial agents
08/21/2014US20140235582 Hiv replication inhibitors
08/21/2014US20140234939 Benzamide Compounds and Related Methods of Use
08/21/2014US20140234333 Compositions and methods for inhibition of the jak pathway
08/20/2014EP2767536A1 Isoxazolo-pyridine derivatives
08/20/2014EP2767532A1 Novel compound for imaging tau protein accumulated in the brain
08/20/2014EP2766361A1 8 - carbamoyl - 2 - (2,3- di substituted pyrid - 6 - yl) -1,2,3,4 -tetrahydroisoquinoline derivatives as apoptosis - inducing agents for the treatment of cancer and immune and autoimmune diseases
08/20/2014EP2766360A1 Soluble guanylate cyclase activators
08/20/2014EP2766359A2 Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
08/20/2014EP2766358A1 Novel oxazine derivatives and their use in the treatment of disease
08/20/2014EP2766355A2 Pyrazol-3-ones that activate pro-apoptotic bax
08/20/2014EP2766353A1 2-oxo-piperidinyl derivatives
08/19/2014US8809584 N-substituted-N-phenylethylsulfonamides for the identification of biological and pharmacological activity
08/19/2014US8809545 Aryl pyridine as aldosterone synthase inhibitors
08/19/2014US8809525 1,2,4-triazine-4-amine derivatives
08/19/2014US8809372 Pyridine derivatives
08/19/2014US8809333 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
08/19/2014US8809326 Isoquinolinone Rho kinase inhibitors
08/19/2014US8809317 Antiviral compounds
08/19/2014CA2608367C Compositions and methods for inhibition of the jak pathway
08/14/2014WO2014122474A1 Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
08/14/2014WO2014122066A1 Substituted amino azoles as plant growth regulators
08/14/2014WO2014097151A3 Autotaxin inhibitors
08/14/2014US20140228416 Substituted hydroxamic acids and uses thereof
08/14/2014US20140228394 Inhibitors of cyp 17
08/14/2014US20140228376 Heterocyclic Compounds for the Treatment of CF
08/14/2014US20140228373 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
08/14/2014US20140228371 Quinoline and quinazoline amides as modulators of sodium channels
08/14/2014US20140228368 Pyrimidine pde10 inhibitors
08/14/2014US20140228367 Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors
08/14/2014US20140228365 Thiazole derivatives and use thereof
08/14/2014US20140228363 Tetrasubstituted cyclohexyl compounds as kinase inhibitors
08/14/2014US20140228340 Benzonitrile derivatives as kinase inhibitors
08/14/2014US20140228338 Topical ocular analgesic agents
08/14/2014US20140228321 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
08/14/2014US20140228319 Water soluble salts of aldose reductase inhibitors for treatment of diabetic complications
08/14/2014US20140227320 Anti-viral compounds
08/14/2014US20140227225 HCV Helicase Inhibitors and Methods of Use Thereof
08/13/2014EP2765132A1 Dye compounds, and their use in dye-sensitized solar cells
08/13/2014EP2764867A1 Agents for preventing and treating disorders Involving modulation of the RYR receptors
08/13/2014EP2763998A1 Tri-heterocyclic derivatives, preparation process and uses thereof
08/13/2014EP2763985A1 Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mtor inhibitors
08/13/2014EP2763979A1 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
08/13/2014EP2763978A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors
08/13/2014EP2763971A1 Preparation of micafungin intermediates
08/13/2014EP2763968A1 Herbicidal pyridazinone derivatives
08/13/2014EP2763674A1 Substituted aminothiazoles as inhibitors of cancers, including hepatocellular carcinoma, and as inhibitors of hepatitis virus replication
08/13/2014CN103987711A 作为用于治疗癌症和免疫性和自身免疫性疾病的凋亡诱导剂的8-氨基甲酰基-2-(2,3-二取代吡啶-6-基)-1,2,3,4-四氢异喹啉衍生物 As 8-Carbamoyl for treating cancer and autoimmune diseases, and immune inducing agent apoptosis-2- (2,3-di-substituted pyridin-6-yl) -1,2,3,4- Hydrogen isoquinoline derivatives
08/13/2014CN103987710A 新的*嗪衍生物及它们在治疗疾病中的应用 * New piperazine derivatives and their use in the treatment of diseases
08/13/2014CN103987707A 吡唑-4-基-杂环基-甲酰胺化合物以及使用方法 Pyrazol-4-yl - heterocyclyl - carboxamide compound, and use of
08/13/2014CN103980268A 一种噻二唑化合物及其合成方法 One kind of thiadiazole compounds and synthetic methods
08/13/2014CN103980267A 一类新型黄嘌呤氧化酶抑制剂的化合物及其药物组合物 A new class of compounds and drugs xanthine oxidase inhibitor compositions
08/13/2014CN103980251A 常山碱衍生物及其在制备抗耐药菌药物中的应用 Febrifugine derivatives and their use in the preparation of the anti-drug-resistant
08/13/2014CN103980228A 具有快速皮肤穿透速度的带正电荷的水溶性的昔康及其相关化合物的前药 Prodrug with a fast rate of penetration of the skin of positively charged water-soluble meloxicam and related compounds
08/13/2014CN102603726B 具有除草活性的5-（2-芳氨基噻唑-4-基）呋喃酚醚类化合物及其制备方法 Having herbicidal activity of 5- (2-aryl-amino-thiazol-4-yl) furan-phenol ether compound and its preparation method
08/13/2014CN102596939B 用于有机发光二极管发射层的化合物 The organic compound layer for the light emitting diode
08/13/2014CN102558165B 用作iap抑制剂的smac肽模拟物 Used iap peptidomimetic inhibitor smac
08/13/2014CN102216285B 四取代的哒嗪hedgehog途径拮抗剂 Tetra-substituted pyridazine hedgehog pathway antagonists
08/13/2014CN101616586B 治疗糖尿病和代谢性病症的杂环受体激动剂 Heterocyclic receptor agonist treatment of diabetes and metabolic disorders
08/13/2014CN101605781B 芳基羧酸环己基酰胺衍生物 Aryl carboxylic acid cyclohexyl amide derivatives
08/12/2014US8802975 Compounds for organic thin-film solar cells and organic thin-film solar cells
08/12/2014US8802861 Thiazole derivatives and use thereof
08/12/2014US8802721 Thiophene compounds for inflammation and immune-related uses
08/12/2014US8802675 Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
08/12/2014US8802673 Heterocyclic amine derivatives
08/12/2014US8802665 Pyrrolidine derivatives
08/12/2014US8802664 Benzazole derivatives as histamine H4 receptor ligands
08/12/2014CA2707648C Isoxazolo-pyridine derivatives
08/12/2014CA2600367C Process for preparing macrocyclic compounds
08/07/2014WO2014120815A1 Quinoline and quinazoline amides as modulators of sodium channels
08/07/2014WO2014120658A1 Fused multicyclic 3-amino-5,6-dihydro-2h-1,4-thiazine derivatives and their use as beta-secretase inhibitors
08/07/2014WO2014118186A1 Amino-substituted isothiazoles
08/07/2014WO2014118143A1 Microbiocidal pyrazole derivatives
08/07/2014WO2014118142A1 Microbiocidal pyrazole derivatives
08/07/2014WO2014074940A9 Crystalline forms of (1s)-1-[5-({3-[(2-methylpyridin-3-yl)oxy]-5-(pyridin-2-ylsulfanyl)pyridin-2-yl}amino)-1,2,4-thiadiazol-3-yl]ethane-1,2-diol
08/07/2014US20140221666 Human protein tyrosine phosphatase inhibitors and methods of use
08/07/2014US20140221663 Process for the preparation of benzohetero [1,3] - diazole compounds disubstituted with heteoaryl groups
08/07/2014US20140221653 Prodrugs of NH-Acidic Compounds
08/07/2014US20140221433 N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
08/07/2014US20140221421 Therapeutic compounds
08/07/2014US20140221411 2-hydroxyarylamide derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient
08/07/2014US20140221405 Platelet adp receptor inhibitors
08/07/2014US20140221387 Compositions and methods useful for treating diseases
08/07/2014US20140221383 Cetp inhibitors
08/07/2014US20140221374 Raf kinase inhibitors
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 628